Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 6, 2026
Navigating Disappearing Liver Metastases in Colorectal Cancer: A Review of Surgical and Non-Surgical Approaches
I Valle, C Conticello, D Ravizza, et al.
ESMO Open
|
June 4, 2024
Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibition
D Marinelli, A Sabatini, E Bengala, et al.
Recenti Progressi in Medicina
|
April 1, 1990
[Increase of liver enzymes during treatment of myocardial infarct using intravenous nitro-derivatives]
E Borghi, D Rossini, N Giomi, et al.
Analytica Chimica Acta
|
August 21, 2016
Innovative combination of QuEChERS extraction with on-line solid-phase extract purification and pre-concentration, followed by liquid chromatography-tandem mass spectrometry for the determination of non-steroidal anti-inflammatory drugs and their metabolites in sewage sludge
D Rossini, L Ciofi, C Ancillotti, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
February 5, 2019
Identification of a novel protein in the genome sequences of Leptospira interrogans with the ability to interact with host's components
A D Rossini, A F Teixeira, A Souza Filho, et al.
ESMO Open
|
October 24, 2021
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
D Rossini, A Boccaccino, A Sbrana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer
M Suenaga, M Schirripa, S Cao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2016
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials
C Cremolini, F Loupakis, G Masi, et al.
ESMO Open
|
February 5, 2025
Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE study
C Antoniotti, M Carullo, D Rossini, et al.
ESMO Open
|
April 17, 2024
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience
R Moretto, M M Germani, B Borelli, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 6, 2026
Navigating Disappearing Liver Metastases in Colorectal Cancer: A Review of Surgical and Non-Surgical Approaches
I Valle, C Conticello, D Ravizza, et al.
ESMO Open
|
June 4, 2024
Systemic treatment of mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer-single versus double checkpoint inhibition
D Marinelli, A Sabatini, E Bengala, et al.
Recenti Progressi in Medicina
|
April 1, 1990
[Increase of liver enzymes during treatment of myocardial infarct using intravenous nitro-derivatives]
E Borghi, D Rossini, N Giomi, et al.
Analytica Chimica Acta
|
August 21, 2016
Innovative combination of QuEChERS extraction with on-line solid-phase extract purification and pre-concentration, followed by liquid chromatography-tandem mass spectrometry for the determination of non-steroidal anti-inflammatory drugs and their metabolites in sewage sludge
D Rossini, L Ciofi, C Ancillotti, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
February 5, 2019
Identification of a novel protein in the genome sequences of Leptospira interrogans with the ability to interact with host's components
A D Rossini, A F Teixeira, A Souza Filho, et al.
ESMO Open
|
October 24, 2021
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
D Rossini, A Boccaccino, A Sbrana, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer
M Suenaga, M Schirripa, S Cao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2016
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials
C Cremolini, F Loupakis, G Masi, et al.
ESMO Open
|
February 5, 2025
Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE study
C Antoniotti, M Carullo, D Rossini, et al.
ESMO Open
|
April 17, 2024
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience
R Moretto, M M Germani, B Borelli, et al.
Page
of 6